Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation [Phase 4]
Phase 4 clinical trial update indicating completion of studies on peri-procedural dabigatran anticoagulation during radiofrequency ablation …
-
CLINICAL_TRIALS research · 2017-11-06Clinical Trial Update: Continuous Versus Discontinuous Design of Encircling Lesions During Ablation for Atrial Fibrillation [NA]
This trial update describes a study comparing continuous versus discontinuous encircling lesion design during atrial fibrillation ablation; …
-
FDA approval · 2017-11-03FDA Approved: FLECAINIDE ACETATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves the original application for flecainide acetate by Rising Pharma Holdings, Inc., providing a generic antiarrhythmic product. In…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: WATCHMAN for Second Prevention of Stroke (WASPS)
The document describes a WASPS trial evaluating the WATCHMAN left atrial appendage closure device for secondary stroke prevention in atrial …
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation
A clinical trial update indicates that the study NCT01733160 evaluating stroke prevention and rhythm interventions in atrial fibrillation ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-10-25FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (AuroMedics Pharma LLC)
The FDA approved the original ANDA for amiodarone hydrochloride, a generic antiarrhythmic, from AuroMedics Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy [Phase 4]
Phase 4 trial evaluating apixaban versus vitamin K antagonist therapy during atrial fibrillation catheter ablation.
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter [Phase 3]
A Phase 3 trial compares different ablation approaches to determine outcomes in patients with coexisting atrial fibrillation and atrial flut…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation [NA]
This clinical trial update summarizes the outcomes of atrial fibrillation ablation after permanent pulmonary vein antrum isolation, with or …
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
A completed clinical trial evaluates whether cardiac biomarkers can predict outcomes in patients with atrial fibrillation undergoing cathete…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Subclinical Postoperative Atrial Fibrillation [NA]
This clinical trial update concerns subclinical postoperative atrial fibrillation sponsored by Sheba Medical Center; the current status is U…
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: Atrial Fibrillation After Cardiac Surgery-comparing Conventional and Miniaturized Bypass Systems [NA]
This clinical trial update reports on atrial fibrillation after cardiac surgery and compares conventional cardiopulmonary bypass with miniat…
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: SMART-SF Radiofrequency Ablation Safety Study [Phase 3]
Phase 3 results from the SMART-SF Radiofrequency Ablation Safety Study in atrial fibrillation have been posted, evaluating the safety profil…
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe
Completed trial evaluating potential off-label use of dabigatran etexilate in Europe for atrial fibrillation; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: LAAO With DAPT Versus Antithrombotic Therapy
This clinical trial compares left atrial appendage occlusion with dual antiplatelet therapy to standard antithrombotic therapy in patients w…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation [Phase 4]
This update notes the completion of the Phase 4 Contact PVI trial evaluating tissue-contact data to guide atrial fibrillation ablation. The …
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Benefit of CFAE Ablation [NA]
A clinical trial update reports on the potential benefit of CFAE ablation for persistent atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: Atrial Fibrillation and Premature Atrial Complexes in Patients With Ischemic Stroke.
The clinical trial on atrial fibrillation and premature atrial complexes in patients with ischemic stroke has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin [Phase 2]
A Phase 2 study evaluating the safety, tolerability, and pilot efficacy of oral betrixaban versus warfarin for atrial fibrillation has compl…
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter [Phase 2]
Phase 2 trial updating the pharmacokinetics and safety of MK-4448 in participants with atrial fibrillation or atrial flutter has been comple…
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism [Phase 4]
Phase 4 trial update evaluating dabigatran etexilate for prevention of stroke and thromboembolism in atrial fibrillation and atrial flutter.
-
CLINICAL_TRIALS trial_result · 2017-09-08Clinical Trial Update: Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery [Phase 2, Phase 3]
Clinical trial update on botulinum toxin injection into epicardial fat pads to prevent atrial fibrillation in patients undergoing cardiac su…
-
CLINICAL_TRIALS trial_result · 2017-09-08Clinical Trial Update: Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI [Phase 2]
Phase 2 trial update comparing left atrial appendage closure to standard antiplatelet therapy in patients with atrial fibrillation undergoin…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation [NA]
This clinical trial update notes the completion and posting of results for a randomized study evaluating warfarin use during pacemaker or IC…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Screening for Actionable Atrial Fibrillation During Preoperative Consultation With the MyDiagnostick
The trial evaluated screening for actionable atrial fibrillation during preoperative consultations using the MyDiagnostick device. The study…